REVANCE THERAPEUTICS INC's ticker is and the CUSIP is 761330AB5. A total of 28 filers reported holding REVANCE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $23,999,000 | -9.0% | 26,199,000 | +8.3% | 0.67% | -3.6% |
| Q3 2022 | $26,377,000 | +112.2% | 24,199,000 | +61.3% | 0.70% | +31.8% |
| Q2 2022 | $12,432,000 | -73.8% | 15,000,000 | -69.7% | 0.53% | -63.4% |
| Q1 2022 | $47,535,000 | +67.4% | 49,500,000 | +54.7% | 1.45% | +3.1% |
| Q4 2021 | $28,400,000 | – | 32,000,000 | – | 1.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 20,087 | $23,535,000 | 2.18% |
| ZAZOVE ASSOCIATES LLC | 15,910,000 | $18,551,000 | 1.66% |
| SSI INVESTMENT MANAGEMENT LLC | 4,487,000 | $5,231,000 | 0.34% |
| DeepCurrents Investment Group LLC | 4,918,000 | $5,752,000 | 0.17% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 3,000,000 | $3,500,000 | 0.05% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 12,500,000 | $14,646,000 | 0.03% |
| Citadel Advisors | 104,329,000 | $122,081,000 | 0.03% |
| LAZARD ASSET MANAGEMENT LLC | 20,000,000 | $23,433,000 | 0.03% |
| WOLVERINE ASSET MANAGEMENT LLC | 2,918,000 | $3,416,000 | 0.03% |
| FRANKLIN RESOURCES INC | 48,000,000 | $56,240,000 | 0.02% |